PI
TEVA icon

PFG Investments’s Teva Pharmaceuticals TEVA Stock Holding History

PFG Investments’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$679K Buy
20,043
+178
+0.9% +$5.93K 0.03% 533
2026
Q1 		$598K Sell
19,865
-683
-3% -$22K 0.03% 539
2025
Q4 		$641K Sell
20,548
-450
-2% -$11.1K 0.03% 472
2025
Q3 		$424K Buy
20,998
+2,850
+16% +$50.1K 0.02% 605
2025
Q2 		$304K Buy
18,148
+2,013
+12% +$32.5K 0.02% 729
2025
Q1 		$248K Hold
16,135
– – 0.02% 788
2024
Q4 		$356K Sell
16,135
-1,300
-7% -$23.7K 0.02% 635
2024
Q3 		$314K Hold
17,435
– – 0.02% 690
2024
Q2 		$283K Sell
17,435
-1,600
-8% -$24.6K 0.02% 677
2024
Q1 		$269K Buy
+19,035
New +$240K 0.02% 787

Other funds holding TEVA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return

PFG Investments's TEVA Position: Q2 2026 in Review

PFG Investments increased its Teva Pharmaceuticals (TEVA) stake by 0.9% in Q2 2026, buying an estimated $5.93K and bringing the position to 20,043 shares worth $679K. The position accounts for 0.03% of the portfolio, ranked #533.

PFG Investments first reported a position in TEVA in Q1 2024 and has held it in 10 quarters since. 673 funds tracked by Wall St. Rank hold TEVA as of Q2 2026.

  • PFG Investments held 20,043 shares of Teva Pharmaceuticals worth $679K as of Q2 2026.
  • PFG Investments bought 178 Teva Pharmaceuticals shares in Q2 2026, an estimated $5.93K.
  • Teva Pharmaceuticals made up 0.03% of PFG Investments's portfolio in Q2 2026, its #533 holding.
  • PFG Investments first reported a position in Teva Pharmaceuticals in Q1 2024 and has held it in 10 quarters since.
  • 673 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q2 2026.

Based on PFG Investments's 13F filing for Q2 2026, filed 23 Jul 2026.